MMV390048 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Participants
Status:
Terminated
Trial end date:
2014-12-19
Target enrollment:
Participant gender:
Summary
A single-centre, open-label, study using induced blood stage malaria infection to
characterize the activity of MMV390048 against early Plasmodium falciparum blood stage
infection.